Search results
Results From The WOW.Com Content Network
KBR (KBR) delivered earnings and revenue surprises of 3.17% and 0.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
KBR (KBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KBR, Inc. (formerly Kellogg Brown & Root) is a U.S. based company operating in fields of science, technology and engineering. [ 2 ] KBR works in various markets including aerospace, defense, industrial and intelligence. [ 3 ]
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the ...
For premium support please call: 800-290-4726 more ways to reach us
Korea Biomedical Review [3] (Korean: 코리아 바이오메디칼 리뷰), abbreviated as KBR, [4] is a South Korea-based [5] online English-language newspaper that mainly delivers news related to the field of healthcare in South Korea.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us